Pisa syndrome (PS) is characterized by an abnormally sustained posture with flexion of the body and head to one side and slight axial rotation of the trunk. PS has been related to the use of neuroleptics and is clinically classified as either an acute or a tardive dystonia. This is the first report describing a case of late-onset PS, occurring in a young patient treated with aripiprazole for 2 years. To establish optimal treatment management, we reviewed the literature on aripiprazole-induced PS and tardive dystonia. In light of current knowledge, we proposed a multistep algorithm to aid in the clinical management of this condition.

De Risio, L., Pettorruso, M., Di Nicola, M., Martinotti, G., Janiri, L., Fasano, A., Management of aripiprazole-induced tardive Pisa syndrome: A case report and literature review, <<INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY>>, 2016; 31 (1): 57-60. [doi:10.1097/YIC.0000000000000099] [http://hdl.handle.net/10807/94659]

Management of aripiprazole-induced tardive Pisa syndrome: A case report and literature review

De Risio, Luisa
;
Pettorruso, Mauro
Secondo
;
Di Nicola, Marco;Martinotti, Giovanni;Janiri, Luigi
Penultimo
;
2016

Abstract

Pisa syndrome (PS) is characterized by an abnormally sustained posture with flexion of the body and head to one side and slight axial rotation of the trunk. PS has been related to the use of neuroleptics and is clinically classified as either an acute or a tardive dystonia. This is the first report describing a case of late-onset PS, occurring in a young patient treated with aripiprazole for 2 years. To establish optimal treatment management, we reviewed the literature on aripiprazole-induced PS and tardive dystonia. In light of current knowledge, we proposed a multistep algorithm to aid in the clinical management of this condition.
2016
Inglese
De Risio, L., Pettorruso, M., Di Nicola, M., Martinotti, G., Janiri, L., Fasano, A., Management of aripiprazole-induced tardive Pisa syndrome: A case report and literature review, <<INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY>>, 2016; 31 (1): 57-60. [doi:10.1097/YIC.0000000000000099] [http://hdl.handle.net/10807/94659]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/94659
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 4
  • ???jsp.display-item.citation.isi??? 3
social impact